Skip to Content
Merck
  • Total Synthesis of Emmyguyacins A and B, Potential Fusion Inhibitors of Influenza Virus.

Total Synthesis of Emmyguyacins A and B, Potential Fusion Inhibitors of Influenza Virus.

Organic letters (2018-10-24)
Santanu Jana, Vikram A Sarpe, Suvarn S Kulkarni
ABSTRACT

Fungal glycolipids emmyguyacins A and B inhibit the pH-dependent conformational change of hemaglutinin A during replication of the Influenza virus. Herein, we report the first total synthesis and structure confirmation of emmyguyacins A and B. Our efficient route, which involves regioselective functionalization of trehalose, allows rapid access to adequate amounts of chemically pure emmyguyacin analogues including the desoxylate derivatives for SAR studies.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Methyl 11-bromoundecanoate, 95%